NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE252128 Query DataSets for GSE252128
Status Public on Oct 22, 2024
Title Characterization of SMA Type II Skeletal Muscle from Treated Patients shows Mitochondrial Deficiency and Denervation
Organism Homo sapiens
Experiment type Expression profiling by high throughput sequencing
Summary Spinal muscular atrophy (SMA) is a recessive, developmental disorder caused by the genetic loss or mutation of the gene SMN1 (Survival of Motor Neuron 1). SMA is characterized by neuromuscular symptoms and muscle weakness. Several years ago, SMA treatment underwent a radical transformation, with the approval of three different SMN-dependent disease modifying therapies. This includes two SMN2 splicing therapies - Risdiplam and Nusinersen. One main challenge for Type II SMA patients treated with these drugs is ongoing muscle fatigue, limited mobility, and other skeletal problems. To date, few molecular studies have been conducted on SMA-patient derived tissues after treatment, limiting our understanding of what targets remain after the principal spinal cord targeted therapies are applied. Therefore, we collected paravertebral muscle from eight Type II patients undergoing spinal surgery for scoliosis and seven controls. We used RNA-sequencing to characterize their transcriptional profiles and correlate these with muscle histology. Despite the limited cohort size and heterogeneity, we observed a consistent loss of oxidative phosphorylation machinery of the mitochondria, a decrease in mitochondrial DNA copy number, and a correlation between signals of cellular stress, denervation and increased fibrosis. This work provides new putative targets for combination therapies for Type II SMA.
 
Overall design RNA was extracted from paravetebral muscle tissue from consented patients undergoing spinal surgery, and libraries were generated with the Takara SMART-seq v4 kit for low-input samples. All RNA used for this study had a RIN value of >6.
Web link https://insight.jci.org/articles/view/180992
 
Contributor(s) Grandi F, Smeriglio P, Astord S
Citation missing Has this study been published? Please login to update or notify GEO.
Submission date Dec 27, 2023
Last update date Oct 22, 2024
Contact name Fiorella Grandi
E-mail(s) fiorella.grandi0@gmail.com
Organization name Sorbonne Universite
Department Centre de Recherche de Myologie
Lab UMRS 974
Street address 105 Bld d'Hopital
City Paris
ZIP/Postal code 75013
Country France
 
Platforms (1)
GPL24676 Illumina NovaSeq 6000 (Homo sapiens)
Samples (15)
GSM7994798 Control_PVMusc01
GSM7994799 Control_PVMusc02
GSM7994800 Control_PVMusc03
Relations
BioProject PRJNA1057835

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE252128_salmon.merged.gene_counts.tsv.gz 1.2 Mb (ftp)(http) TSV
GSE252128_salmon.merged.gene_tpm.tsv.gz 2.2 Mb (ftp)(http) TSV
GSE252128_salmon.merged.transcript_counts.tsv.gz 4.0 Mb (ftp)(http) TSV
SRA Run SelectorHelp
Raw data are available in SRA

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap